37 results Séminaire Compliance & Sustainability Le lundi 12 juin, Stibbe organise le séminaire Compliance & Sustainability. N'hésitez pas à vous inscrire. Seminarie Compliance & Sustainability Op maandag 12 juni organiseert Stibbe het seminarie Compliance & Sustainability. Aarzel niet om u in te schrijven. Stibbe appoints two new partners Stibbe Brussels proudly announces the promotions of Guan Schaiko (Environment & Planning) and Pieter Nobels (Banking & Finance) to partner. The new appointments will take effect on 1 July 2022. Stibbe nomme deux nouveaux associés Le bureau bruxellois de Stibbe est fier d'annoncer la promotion de Guan Schaiko (Environment & Planning) et de Pieter Nobels (Banking & Finance) au titre d'associé. Les nouvelles nominations prendront effet le 1er juillet 2022. Stibbe benoemt twee nieuwe partners Het Brusselse kantoor van Stibbe heeft Guan Schaiko (Environment & Planning) en Pieter Nobels (Banking & Finance) als partners benoemd. De nieuwe benoemingen gaan in op 1 juli 2022. Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients. Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Pagination Current page 1 Page 2 Page 3 Next page
Séminaire Compliance & Sustainability Le lundi 12 juin, Stibbe organise le séminaire Compliance & Sustainability. N'hésitez pas à vous inscrire.
Seminarie Compliance & Sustainability Op maandag 12 juni organiseert Stibbe het seminarie Compliance & Sustainability. Aarzel niet om u in te schrijven.
Stibbe appoints two new partners Stibbe Brussels proudly announces the promotions of Guan Schaiko (Environment & Planning) and Pieter Nobels (Banking & Finance) to partner. The new appointments will take effect on 1 July 2022.
Stibbe nomme deux nouveaux associés Le bureau bruxellois de Stibbe est fier d'annoncer la promotion de Guan Schaiko (Environment & Planning) et de Pieter Nobels (Banking & Finance) au titre d'associé. Les nouvelles nominations prendront effet le 1er juillet 2022.
Stibbe benoemt twee nieuwe partners Het Brusselse kantoor van Stibbe heeft Guan Schaiko (Environment & Planning) en Pieter Nobels (Banking & Finance) als partners benoemd. De nieuwe benoemingen gaan in op 1 juli 2022.
Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.